ID   LNCaP clone FGC.10
AC   CVCL_W668
SY   LNCaP clone FGC-10; LNCaP-FGC-10; LNcap-FGC-10; LNCaP FGC-10
DR   cancercelllines; CVCL_W668
DR   IZSLER; BS TCL 187
DR   NCBI_Iran; C439
DR   Wikidata; Q54902826
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10995.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
ST   Source(s): IZSLER
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12,13
ST   D16S539: 11,12
ST   D21S11: 29,32.2
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 17
//